Sphera Funds Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,097
| Closed | -$876K | – | 129 |
|
|
2025
Q1 | $876K | Sell |
26,097
-26,000
| -50% | -$872K | 0.2% | 92 |
|
|
2024
Q4 | $2.04M | Buy |
+52,097
| New | +$2.04M | 0.37% | 79 |
|
|
2023
Q4 | – | Sell |
-38,959
| Closed | -$1.33M | – | 98 |
|
|
2023
Q3 | $1.33M | Buy |
+38,959
| New | +$1.33M | 0.24% | 64 |
|
|
2021
Q4 | – | Sell |
-373,510
| Closed | -$5.71M | – | 118 |
|
|
2021
Q3 | $5.71M | Buy |
373,510
+97,380
| +35% | +$1.49M | 0.48% | 54 |
|
|
2021
Q2 | $51.4M | Buy |
+276,130
| New | +$51.4M | 3.48% | 4 |
|
|
2019
Q2 | – | Sell |
-533,655
| Closed | -$5.42M | – | 104 |
|
|
2019
Q1 | $5.42M | Buy |
533,655
+84,171
| +19% | +$855K | 0.49% | 42 |
|
|
2018
Q4 | $2.84M | Buy |
449,484
+70,000
| +18% | +$442K | 0.32% | 65 |
|
|
2018
Q3 | $5.01M | Sell |
379,484
-59,550
| -14% | -$786K | 0.58% | 47 |
|
|
2018
Q2 | $4.04M | Buy |
+439,034
| New | +$4.04M | 0.56% | 52 |
|
|
2017
Q4 | – | Sell |
-228,029
| Closed | -$673K | – | 146 |
|
|
2017
Q3 | $673K | Hold |
228,029
| – | – | 0.1% | 99 |
|
|
2017
Q2 | $718K | Sell |
228,029
-100,000
| -30% | -$315K | 0.12% | 100 |
|
|
2017
Q1 | $1.31M | Hold |
328,029
| – | – | 0.26% | 79 |
|
|
2016
Q4 | $2.53M | Buy |
328,029
+100,000
| +44% | +$770K | 0.64% | 44 |
|
|
2016
Q3 | $1.85M | Buy |
+228,029
| New | +$1.85M | 0.3% | 70 |
|